Mechanistic Modeling of Amyloid Oligomer and Protofibril Formation in Bovine Insulin.


Journal

Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 23 10 2023
revised: 22 01 2024
accepted: 26 01 2024
medline: 18 3 2024
pubmed: 2 2 2024
entrez: 1 2 2024
Statut: ppublish

Résumé

Early phase of amyloid formation, where prefibrillar aggregates such as oligomers and protofibrils are often observed, is crucial for understanding pathogenesis. However, the detailed mechanisms of their formation have been difficult to elucidate because they tend to form transiently and heterogeneously. Here, we found that bovine insulin protofibril formation proceeds in a monodisperse manner, which allowed us to characterize the detailed early aggregation process by light scattering in combination with thioflavin T fluorescence and Fourier transform infrared spectroscopy. The protofibril formation was specific to bovine insulin, whereas no significant aggregation was observed in human insulin. The kinetic analysis combining static and dynamic light scattering data revealed that the protofibril formation process in bovine insulin can be divided into two steps based on fractal dimension. When modeling the experimental data based on Smoluchowski aggregation kinetics, an aggregation scheme consisting of initial fractal aggregation forming spherical oligomers and their subsequent end-to-end association forming protofibrils was clarified. Furthermore, the analysis of temperature and salt concentration dependencies showed that the end-to-end association is the rate-limiting step, involving dehydration. The established model for protofibril formation, wherein oligomers are incorporated as a precursor, provides insight into the molecular mechanism by which protein molecules assemble during the early stage of amyloid formation.

Identifiants

pubmed: 38301805
pii: S0022-2836(24)00027-5
doi: 10.1016/j.jmb.2024.168461
pii:
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Insulins 0
Amyloid beta-Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168461

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Keisuke Yuzu (K)

Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Hyogo 657-8501, Japan.

Hiroshi Imamura (H)

Department of Bio-Science, Nagahama Institute of Bio-Science and Technology, 1266 Tamura, Nagahama, Shiga 526-0829, Japan.

Takuro Nozaki (T)

Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Hyogo 657-8501, Japan.

Yuki Fujii (Y)

Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Hyogo 657-8501, Japan.

Shaymaa Mohamed Mohamed Badawy (SMM)

Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Hyogo 657-8501, Japan; Department of Agricultural Biochemistry, Faculty of Agriculture, Zagazig University, Zagazig, Egypt.

Ken Morishima (K)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.

Aya Okuda (A)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.

Rintaro Inoue (R)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.

Masaaki Sugiyama (M)

Institute for Integrated Radiation and Nuclear Science, Kyoto University, Kumatori, Osaka 590-0494, Japan.

Eri Chatani (E)

Department of Chemistry, Graduate School of Science, Kobe University, Kobe, Hyogo 657-8501, Japan. Electronic address: chatani@crystal.kobe-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH